// App-Quantinova.ai

1356 : Impact of Etiological Cytogenetic Abnormalities on Immunoparesis and Progression-Free and Overall Survival in Newly Diagnosed Multiple Myeloma

Researchers

Presenter

  • Jessica Caro

Principal Investigators

  • David Cairns

  • Tom Menzies

  • Charlotte Pawlyn

  • Eileen M Boyle

  • Gareth Morgan

  • Gordon Cook

  • Martin F. Kaiser

  • Roger G Owen

  • Walter M Gregory

  • Graham H Jackson

  • Brian Walker

  • Jennifer LJ Heaney

  • Mark T Drayson

  • Faith E. Davies

Medical Centers

  • Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY

  • Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

  • Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

  • Institute for Cancer Research, London, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • St. James's University Hospital, Leeds, United Kingdom

  • Department of haematological sciences, Newcastle University, Newcastle-Upon-Tyne, United Kingdom,

  • Indiana University School of Medicine, Bloomington, IN

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 79A

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved